Similar articles

• Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.

  Middleton PG, Geddes DM, Alton EW. Middleton PG, et al. Eur Respir J. 1994 Nov;7(11):2050-6. Eur Respir J. 1994. PMID: 7875281
• Basic protocol for transepithelial nasal potential difference measurements.

  Schüler D, Sermet-Gaudelus I, Wilschanski M, Ballmann M, Dechaux M, Edelman A, Hug M, Leal T, Lebacq J, Lebecque P, Lenoir G, Stanke F, Wallemacq P, Tümmler B, Knowles MR. Schüler D, et al. J Cyst Fibros. 2004 Aug;3 Suppl 2:151-5. doi: 10.1016/j.jcf.2004.05.032. J Cyst Fibros. 2004. PMID: 15463949 Review.
• A new device for in vivo measurement of nasal transepithelial potential difference in cystic fibrosis patients and normal subjects.

  Duperrex O, Berclaz PY, Bertrand D, Lacroix JS, Pochon N, Belli D, Rochat T. Duperrex O, et al. Eur Respir J. 1997 Jul;10(7):1631-6. doi: 10.1183/09031936.97.10071631. Eur Respir J. 1997. PMID: 9230258
• Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.

  Sweezey NB, Smith D, Corey M, Ellis L, Carpenter S, Tullis DE, Durie P, O'Brodovich HM. Sweezey NB, et al. Pediatr Pulmonol. 2007 Jun;42(6):519-24. doi: 10.1002/ppul.20624. Pediatr Pulmonol. 2007. PMID: 17469152
• Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers.

  De Jonge HR, Ballmann M, Veeze H, Bronsveld I, Stanke F, Tümmler B, Sinaasappel M. De Jonge HR, et al. J Cyst Fibros. 2004 Aug;3 Suppl 2:159-63. doi: 10.1016/j.jcf.2004.05.034. J Cyst Fibros. 2004. PMID: 15463951 Review.